530 - Treatment Efficacy in Patients with Moderate-to-severe Atopic Dermatitis Who Switched from Dupilumab to Abrocitinib in JADE EXTEND, a Phase 3 Long-Term Extension Study
British Journal of Dermatology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要